- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe dry eye syndrome
- Meeting Date: November 2025
- Public Summary Document (PSD) November 2025 PBAC Meeting - (PDF 1.2MB)
- Public Summary Document (PSD) November 2025 PBAC Meeting - (Word 1.2MB)
Polyethylene glycol 400 with propylene glycol – November 2025
Polyethylene glycol 400 with propylene glycol: Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 28; Systane® - November 2025
Last updated
5 November 2025